Compared to Estimates, Standex (SXI) Q2 Earnings: A Look at Key Metrics

Standex International (SXI) reported $221.32 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 16.6%. EPS of $2.08 for the same period compares to $1.91 a year ago.

The reported revenue represents a surprise of +1.23% over the Zacks Consensus Estimate of $218.63 million. With the consensus EPS estimate being $2.00, the EPS surprise was +3.87%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Standex performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net sales- Scientific: $19.5 million versus $18.85 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.6% change.
• Net sales- Specialty Solutions: $19.79 million compared to the $22.1 million average estimate based on two analysts. The reported number represents a change of -7.2% year over year.
• Net sales- Electronics: $115.67 million versus the two-analyst average estimate of $112.05 million. The reported number represents a year-over-year change of +20.6%.
• Net Sales- Engraving: $35.73 million versus $32.4 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +13.6% change.
• Net Sales- Engineered Technologies: $30.64 million versus the two-analyst average estimate of $32.55 million. The reported number represents a year-over-year change of +35.3%.

View all Key Company Metrics for Standex here>>>

Shares of Standex have returned +11.4% over the past month versus the Zacks S&P 500 composite's +0.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 
Standex International Corporation (SXI): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research